New data from the Phase 2 OVATION 2 study highlights potential improvements in survival outcomes with IMUNON's IMNN-001 for ...

Cytokine therapies have the potential to transform cancer treatment by enhancing the body’s immune response to fight cancer ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale.

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially for lung cancer. In this insightful interview with Dr. Nicolas Girard, Head ...